Announcements Trials
Browse Landscape

Phase

Phase 4 1

Status

Withdrawn 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Conditions

Infections 9Lymphoma 7Leukemia 6Neoplasms, Plasma Cell 5Neoplasms 5Precursor Cell Lymphoblastic Leukemia-Lymphoma 3Multiple Myeloma 3Lymphoma, Non-Hodgkin 3Urinary Tract Infections 2Prostatic Neoplasms 2Leukemia, Biphenotypic, Acute 2Waldenstrom Macroglobulinemia 1Urinary Bladder Neoplasms 1Unspecified Adult Solid Tumor, Protocol Specific 1Thrombocythemia, Essential 1Surgical Wound Infection 1Skin Neoplasms 1Sezary Syndrome 1Sepsis 1Primary Myelofibrosis 1Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 1Polycythemia Vera 1Pdgfra-Associated Chronic Eosinophilic Leukemia 1Myeloproliferative Disorders 1Myelodysplastic-Myeloproliferative Diseases 1Myelodysplastic Syndromes 1Mycosis Fungoides 1Lymphoproliferative Disorders 1Lymphoma, T-Cell, Cutaneous 1Lymphoma, Mantle-Cell 1

Interventions

Exercise 5Vitamin D 3Resistance Training 3Omeprazole 3Etanercept 3Dexmedetomidine 3Ascorbic Acid 3salicylsalicylic acid 2palbociclib 2epigallocatechin gallate 2XENP 1595 2Tea 2Tablets 2Sufentanil 2Probiotics 2Nutrition Assessment 2Morphine 2Metformin 2Ketorolac 2Infliximab 2Ibuprofen 2Fish Oils 2Endurance Training 2Colchicine 2Aspirin 2soybean oil, phospholipid emulsion 1montelukast 1microcrystalline cellulose 1ginger extract 1falcarinol 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Interventional × Inflammation × Trimethoprim, Sulfamethoxazole Drug Combination × Clear all
NCT01899690 2017-02-24

Antibiotics and Tissue Expanders in Breast Reconstruction

Emory University

Phase 4 Withdrawn

Infections, Inflammation, Neoplasms, Surgical Wound Infection

Data powered by HemOnc (CC BY 4.0) Colophon âš¡